| Issue Date | Title | Author(s) |
| 2016-12-08 | MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. | Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR |
| 2017-04-18 | Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer. | Valdés-Mora, F; Locke, WJ; Bandrés, E; Gallego-Ortega, D; Cejas, P; García-Cabezas, MA; Colino-Sanguino, Y; Feliú, J; Del Pulgar, TG; Lacal, JC |
| 2015-03-27 | ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype. | Junankar, S; Baker, LA; Roden, DL; Nair, R; Elsworth, B; Gallego-Ortega, D; Lacaze, P; Cazet, A; Nikolic, I; Teo, WS; Yang, J; McFarland, A; Harvey, K; Naylor, MJ; Lakhani, SR; Simpson, PT; Raghavendra, A; Saunus, J; Madore, J; Kaplan, W; Ormandy, C; Millar, EKA; O'Toole, S; Yun, K; Swarbrick, A |
| 2017-04-05 | Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. | Vennin, C; Chin, VT; Warren, SC; Lucas, MC; Herrmann, D; Magenau, A; Melenec, P; Walters, SN; Del Monte-Nieto, G; Conway, JRW; Nobis, M; Allam, AH; McCloy, RA; Currey, N; Pinese, M; Boulghourjian, A; Zaratzian, A; Adam, AAS; Heu, C; Nagrial, AM; Chou, A; Steinmann, A; Drury, A; Froio, D; Giry-Laterriere, M; Harris, NLE; Phan, T; Jain, R; Weninger, W; McGhee, EJ; Whan, R; Johns, AL; Samra, JS; Chantrill, L; Gill, AJ; Kohonen-Corish, M; Harvey, RP; Biankin, AV; Australian Pancreatic Cancer Genome Initiative (APGI),; Evans, TRJ; Anderson, KI; Grey, ST; Ormandy, CJ; Gallego-Ortega, D; Wang, Y; Samuel, MS; Sansom, OJ; Burgess, A; Cox, TR; Morton, JP; Pajic, M; Timpson, P |
| 2021-07-12 | Transcription-coupled structural dynamics of topologically associating domains regulate replication origin efficiency | Li, Y; Xue, B; Zhang, M; Zhang, L; Hou, Y; Qin, Y; Long, H; Su, QP; Wang, Y; Guan, X; Jin, Y; Cao, Y; Li, G; Sun, Y |
| 2016-01 | Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics. | Warkiani, ME; Khoo, BL; Wu, L; Tay, AKP; Bhagat, AAS; Han, J; Lim, CT |
| 2016-12-12 | Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. | Torchia, J; Golbourn, B; Feng, S; Ho, KC; Sin-Chan, P; Vasiljevic, A; Norman, JD; Guilhamon, P; Garzia, L; Agamez, NR; Lu, M; Chan, TS; Picard, D; de Antonellis, P; Khuong-Quang, D-A; Planello, AC; Zeller, C; Barsyte-Lovejoy, D; Lafay-Cousin, L; Letourneau, L; Bourgey, M; Yu, M; Gendoo, DMA; Dzamba, M; Barszczyk, M; Medina, T; Riemenschneider, AN; Morrissy, AS; Ra, Y-S; Ramaswamy, V; Remke, M; Dunham, CP; Yip, S; Ng, H-K; Lu, J-Q; Mehta, V; Albrecht, S; Pimentel, J; Chan, JA; Somers, GR; Faria, CC; Roque, L; Fouladi, M; Hoffman, LM; Moore, AS; Wang, Y; Choi, SA; Hansford, JR; Catchpoole, D; Birks, DK; Foreman, NK; Strother, D; Klekner, A; Bognár, L; Garami, M; Hauser, P; Hortobágyi, T; Wilson, B; Hukin, J; Carret, A-S; Van Meter, TE; Hwang, EI; Gajjar, A; Chiou, S-H; Nakamura, H; Toledano, H; Fried, I; Fults, D; Wataya, T; Fryer, C; Eisenstat, DD; Scheinemann, K; Fleming, AJ; Johnston, DL; Michaud, J; Zelcer, S; Hammond, R; Afzal, S; Ramsay, DA; Sirachainan, N; Hongeng, S; Larbcharoensub, N; Grundy, RG; Lulla, RR; Fangusaro, JR; Druker, H; Bartels, U; Grant, R; Malkin, D; McGlade, CJ; Nicolaides, T; Tihan, T; Phillips, J; Majewski, J; Montpetit, A; Bourque, G; Bader, GD; Reddy, AT; Gillespie, GY; Warmuth-Metz, M; Rutkowski, S; Tabori, U; Lupien, M; Brudno, M; Schüller, U; Pietsch, T; Judkins, AR; Hawkins, CE; Bouffet, E; Kim, S-K; Dirks, PB; Taylor, MD; Erdreich-Epstein, A; Arrowsmith, CH; De Carvalho, DD; Rutka, JT; Jabado, N; Huang, A |
| 2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
| 2016-08-09 | A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner. | Sutton, SK; Carter, DR; Kim, P; Tan, O; Arndt, GM; Zhang, XD; Baell, J; Noll, BD; Wang, S; Kumar, N; McArthur, GA; Cheung, BB; Marshall, GM |
| 2016-12 | PEG Grafted-Nanodiamonds for the Delivery of Gemcitabine. | Lu, M; Wang, Y-K; Zhao, J; Lu, H; Stenzel, MH; Xiao, P |
